Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02319668Phase 4Completed
Phase 4, randomised, open-label trial of chlorhexidine in dental plaque (2 arms), sponsored by GSK. Primary endpoint: Total Number of Detectable Plaque Bacteria Sampled 3 Days Post Implant Surgery. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02319668.